The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Two female medical researchers talking about their research project

RACOON-RESCUE is Advancing Pediatric Non-Hodgkin Lymphoma Care

Pediatric Non-Hodgkin Lymphoma (NHL) is the fourth most common tumor in children and adolescents, yet its radiological methods lack standardization, leaving room for significant improvement.

The RACOON-RESCUE project addresses this gap by uniting pediatric radiologists and oncologists from all German university hospitals to systematically analyze imaging data, aiming to enhance diagnosis, treatment response assessment, and follow-up care for pediatric NHL.

The findings from RACOON-RESCUE aim to support the development of optimized and personalized diagnostic and risk-adapted therapeutic approaches.

Read the full interview with the project leads, Prof. Dr. Diane Renz and Prof. Dr. Wilhelm Wößmann, to learn more about the initiative.

Related Resources

Related Resources

A picture of workshop participants  next to a positive review for the ESOI-EORTC RECIST Workshop in Munich

ESOI-EORTC Workshop on Imaging in Assessing Response to Cancer Therapy - A Participant's Perspective

Following the conclusion of the ESOI-EORTC Workshop on Imaging in Assessing Response to Cancer Therapy in Munich, we were keen to gather feedback…

A diagram and a CT scan visualizing tumor growth rate in patients with refractory or relapsed lymphoma

Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients

A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…